Two controls in a previous study [2] had low titer GABAB-R antibodies and high titer GAD-65 antibodies, and phenotypically resembled a GAD-65 encephalopathy with progressive cerebellar ataxia, rigidity, myoclonus, and gait instability. This evidence concerns the gene GAD2 and aceruloplasminemia.